# US 2026/0096950 A1 · Glass containers for storing pharmaceutical compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0096950 A1
- Document ID: US20260096950A1
- Status: Published application
- Kind: A1
- Application number: 19/351,794
- Filed: 2025-10-07
- Published: 2026-04-09
- Earliest claimed: 2021-09-30
- Assignees: Corning Incorporated
- Applicants: Corning Incorporated
- Inventors: Christy Lynn Chapman; Sinue Gomez-Mower; Weirong Jiang; Joseph Michael Matusick; Christie Leigh McCarthy; Connor Thomas O'Malley; John Stephen Peanasky; Shivani Rao Polasani; James Ernest Webb; Michael Clement Ruotolo, Jr.; Bryan James Musk; Jared Seaman Aaldenberg; Eric Lewis Allington; Douglas Miles Noni, Jr.; Amber Leigh Tremper; Kristen Dae Waight; Kevin Patrick McNelis; Patrick Joseph Cimo; Steven Edward DeMartino; Robert Anthony Schaut; Adam Robert Sarafian
- Web page: https://patentgrep.com/patent/US20260096950A1

## CPC

- A61J 1/06: Ampoules or carpules (syringe ampoules or carpules A61M5/28)
- A61J 1/1468: {Containers characterised by specific material properties}
- B65D 23/0821: {consisting mainly of polymeric materials (B65D23/0828 takes precedence)}
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- B65D: CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES

## Abstract

Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

## Claims

### Claim 1

A glass pharmaceutical vial comprising:
a glass body comprising a sidewall enclosing an interior volume and an outer diameter D, wherein:
the outer diameter D of the glass body is greater than or equal to 84% and less than or equal to 116% of a diameter d1 of a glass vial of size designation X as defined by ISO 8362-1:2018, wherein X is a smallest size designation of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R, as defined by ISO 8362-1:2018, for which 116% of the diameter d1 is greater than or equal to D;
the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size designation X as defined by ISO 8362-1:2018; and
the glass pharmaceutical vial comprises a Dynamic Impact Factor of less than 0.9, as determined in accordance with a Dynamic Impact Test.

### Claim 2 (depends on 1)

The glass pharmaceutical vial of claim 1, wherein the glass pharmaceutical vial comprises a FWHM Factor of at least 1.2, as determined in accordance with the Dynamic Impact Test.

### Claim 3 (depends on 1)

The glass pharmaceutical vial of claim 1, wherein the glass pharmaceutical vial comprises a compliance factor of at least 1.75, as determined in accordance with a Vial Compliance Test.

### Claim 4 (depends on 1)

The glass pharmaceutical vial of claim 1, wherein the glass pharmaceutical vial comprises a coating disposed on at least a portion of an outer surface of the glass body.

### Claim 5 (depends on 4)

The glass pharmaceutical vial of claim 4, wherein the glass pharmaceutical vial comprises a breakage factor of at least 50, as determined in accordance with a Pendulum Impact Test.

### Claim 6 (depends on 4)

The glass pharmaceutical vial of claim 4, wherein the glass pharmaceutical vial comprises a cold storage factor of at least 2.25, as determined in accordance with a Freeze-Thaw Test.

### Claim 7 (depends on 4)

The glass pharmaceutical vial of claim 4, wherein the glass pharmaceutical vial comprises an external organic coating and has an intervention rate, according to an Accumulator Table Experiment, of less than or equal to 0.90×RI, wherein RI is an intervention rate of the glass vial of size designation X as defined by ISO 8362-1:2018.

### Claim 8 (depends on 1)

The glass pharmaceutical vial of claim 1, further comprising:
a shoulder extending from the sidewall;
a neck extending from the shoulder; and
a flange extending from the neck, the flange comprising:
an underside surface extending from the neck; and
an outer surface extending from the underside surface and being radially recessed inwardly thereby defining a cutout portion of the flange.

### Claim 9 (depends on 1)

The glass pharmaceutical vial of claim 1, wherein the glass pharmaceutical vial has a Type 1 chemical durability according to USP <660>.

### Claim 10 (depends on 1)

The glass pharmaceutical vial of claim 1, wherein the sidewall of the glass pharmaceutical vial having an average wall thickness Ti that is less than or equal to 0.85*s1 correlates to a reduction in an amount of energy used to convert the glass pharmaceutical vial from stock glass tubing of greater than or equal to 5%.

### Claim 11 (depends on 1)

The glass pharmaceutical vial of claim 1, wherein the sidewall of the glass pharmaceutical vial having an average wall thickness Ti that is less than or equal to 0.85*s1 correlates to a reduction in an amount of CO2 emitted to produce the glass pharmaceutical vial of greater than or equal to 5%.

### Claim 12

A glass pharmaceutical vial comprising:
a glass body comprising a sidewall enclosing an interior volume and an outer diameter D, wherein:
the outer diameter D of the glass body is greater than or equal to 84% and less than or equal to 116% of a diameter d1 of a glass vial of size designation X as defined by ISO 8362-1:2018, wherein X is a smallest size designation of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R, as defined by ISO 8362-1:2018, for which 116% of the diameter d1 is greater than or equal to D;
the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size designation X as defined by ISO 8362-1:2018; and
the glass pharmaceutical vial comprises a FWHM Factor of at least 1.2, as determined in accordance with a Dynamic Impact Test.

### Claim 13 (depends on 12)

The glass pharmaceutical vial of claim 12, wherein the glass pharmaceutical vial comprises a compliance factor of at least 1.75, as determined in accordance with a Vial Compliance Test.

### Claim 14 (depends on 12)

The glass pharmaceutical vial of claim 12, wherein the glass pharmaceutical vial comprises a coating disposed on at least a portion of an outer surface of the glass body.

### Claim 15 (depends on 14)

The glass pharmaceutical vial of claim 14, wherein the glass pharmaceutical vial comprises a breakage factor of at least 50, as determined in accordance with a Pendulum Impact Test.

### Claim 16 (depends on 14)

The glass pharmaceutical vial of claim 14, wherein the glass pharmaceutical vial comprises a cold storage factor of at least 2.25, as determined in accordance with a Freeze-Thaw Test.

### Claim 17 (depends on 14)

The glass pharmaceutical vial of claim 14, wherein the glass pharmaceutical vial comprises an external organic coating and has an intervention rate, according to an Accumulator Table Experiment, of less than or equal to 0.90×RI, wherein RI is an intervention rate of the glass vial of size designation X as defined by ISO 8362-1:2018.

### Claim 18 (depends on 12)

The glass pharmaceutical vial of claim 12, wherein the glass pharmaceutical vial has a Type 1 chemical durability according to USP <660>.

### Claim 19 (depends on 12)

The glass pharmaceutical vial of claim 12, wherein the sidewall of the glass pharmaceutical vial having an average wall thickness Ti that is less than or equal to 0.85*s1 correlates to a reduction in an amount of energy used to convert the glass pharmaceutical vial from stock glass tubing of greater than or equal to 5%.

### Claim 20 (depends on 12)

The glass pharmaceutical vial of claim 12, wherein the sidewall of the glass pharmaceutical vial having an average wall thickness Ti that is less than or equal to 0.85*s1 correlates to a reduction in an amount of CO2 emitted to produce the glass pharmaceutical vial of greater than or equal to 5%.
